Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Michael Lincoff

Showing results (281-290 of 353) with videos related to

Pageof 36
Sort By:
Journal of the American College of Cardiology|September 26, 2009
Gastrointestinal bleeding in patients with acute coronary syndromes: incidence, predictors, and clinical implications: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trialEugenia Nikolsky, Gregg W Stone, Ajay J Kirtane, et al.
Diabetes Care|June 16, 2018
Adiponectin, Free Fatty Acids, and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Acute Coronary SyndromeIlse C Schrieks, Anna Nozza, Barbara E Stähli, et al.
The American Journal of Cardiology|June 14, 2005
Characterization of myocardial infarction as an end point in two large trials of acute coronary syndromesKenneth W Mahaffey, Matthew T Roe, Rakhi Kilaru, et al.
Journal of the American College of Cardiology|July 20, 2012
2012 ACCF/AHA focused update of the guideline for the management of patients with unstable angina/non-ST-elevation myocardial infarction (updating the 2007 guideline and replacing the 2011 focused update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice GuidelinesHani Jneid, Jeffrey L Anderson, R Scott Wright, et al.
The American Journal of Cardiology|April 15, 2004
Final results of the ReoPro readministration registryJean-Pierre Dery, Gregory A Braden, A Michael Lincoff, et al.
American Heart Journal|January 20, 2021
Rationale and design of the CLEAR-outcomes trial: Evaluating the effect of bempedoic acid on cardiovascular events in patients with statin intoleranceStephenJ Nicholls, A Michael Lincoff, Harold E Bays, et al.
American Heart Journal|April 1, 2009
Rationale, design, and governance of Prospective Randomized Evaluation of Celecoxib Integrated Safety versus Ibuprofen Or Naproxen (PRECISION), a cardiovascular end point trial of nonsteroidal antiinflammatory agents in patients with arthritisMatthew C Becker, Thomas H Wang, Lisa Wisniewski, et al.
Nature Medicine|May 25, 2024
Long-term kidney outcomes of semaglutide in obesity and cardiovascular disease in the SELECT trialHelen M Colhoun, Ildiko Lingvay, Paul M Brown, et al.
Circulation|May 22, 2002
First experience with direct factor Xa inhibition in patients with stable coronary disease: a pharmacokinetic and pharmacodynamic evaluationChristopher K Dyke, Richard C Becker, Neal S Kleiman, et al.
Lancet (London, England)|March 21, 2007
Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a subgroup analysis from the Acute Catheterization and Urgent Intervention Triage strategy (ACUITY) trialGregg W Stone, Harvey D White, E Magnus Ohman, et al.
Pageof 36

Showing results (281-290 of 353) with videos related to

Sort By:
Pageof 36
Journal of the American College of Cardiology|September 26, 2009
Gastrointestinal bleeding in patients with acute coronary syndromes: incidence, predictors, and clinical implications: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trialEugenia Nikolsky, Gregg W Stone, Ajay J Kirtane, et al.
Diabetes Care|June 16, 2018
Adiponectin, Free Fatty Acids, and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Acute Coronary SyndromeIlse C Schrieks, Anna Nozza, Barbara E Stähli, et al.
The American Journal of Cardiology|June 14, 2005
Characterization of myocardial infarction as an end point in two large trials of acute coronary syndromesKenneth W Mahaffey, Matthew T Roe, Rakhi Kilaru, et al.
Journal of the American College of Cardiology|July 20, 2012
2012 ACCF/AHA focused update of the guideline for the management of patients with unstable angina/non-ST-elevation myocardial infarction (updating the 2007 guideline and replacing the 2011 focused update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice GuidelinesHani Jneid, Jeffrey L Anderson, R Scott Wright, et al.
The American Journal of Cardiology|April 15, 2004
Final results of the ReoPro readministration registryJean-Pierre Dery, Gregory A Braden, A Michael Lincoff, et al.
American Heart Journal|January 20, 2021
Rationale and design of the CLEAR-outcomes trial: Evaluating the effect of bempedoic acid on cardiovascular events in patients with statin intoleranceStephenJ Nicholls, A Michael Lincoff, Harold E Bays, et al.
American Heart Journal|April 1, 2009
Rationale, design, and governance of Prospective Randomized Evaluation of Celecoxib Integrated Safety versus Ibuprofen Or Naproxen (PRECISION), a cardiovascular end point trial of nonsteroidal antiinflammatory agents in patients with arthritisMatthew C Becker, Thomas H Wang, Lisa Wisniewski, et al.
Nature Medicine|May 25, 2024
Long-term kidney outcomes of semaglutide in obesity and cardiovascular disease in the SELECT trialHelen M Colhoun, Ildiko Lingvay, Paul M Brown, et al.
Circulation|May 22, 2002
First experience with direct factor Xa inhibition in patients with stable coronary disease: a pharmacokinetic and pharmacodynamic evaluationChristopher K Dyke, Richard C Becker, Neal S Kleiman, et al.
Lancet (London, England)|March 21, 2007
Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a subgroup analysis from the Acute Catheterization and Urgent Intervention Triage strategy (ACUITY) trialGregg W Stone, Harvey D White, E Magnus Ohman, et al.
Pageof 36